Calcium folinate pentahydrate
Ann Arbor Stage III Hodgkin Lymphoma
OHSU Knight Cancer InstituteSmall moleculePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Ann Arbor Stage III Hodgkin Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VINBLASTINE National Cancer Institute (NCI) | Phase 3 | BB |
Tazemetostat National Cancer Institute (NCI) | Phase 2 | B |
Idelalisib OHSU Knight Cancer Institute | Phase 2 | CCC |
Capecitabine OHSU Knight Cancer Institute | Phase 1 | CC |
su011248 OHSU Knight Cancer Institute | Phase 1 | CC |
View all 38 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →